Urology
Douglas Dahl, MD
Chief of Urologic Oncology, Massachusetts General Hospital Department of Urology
Douglas M. Dahl, MD, FACS, serves as Chief of Urologic Oncology in the Department of Urology at Massachusetts General Hospital in Boston, specializing in urologic oncology and minimally invasive surgical techniques. He treats a range of urologic malignancies, including kidney cancer, bladder cancer, prostate cancer, and renal cell carcinoma. Dr. Dahl is renowned for pioneering laparoscopic radical prostatectomy and partial nephrectomy, now standard in clinical practice, and has developed innovat
30+
Years in Practice
Credentials
Board Certifications
- Urology (American Board of Urology, 2000)
Education & Training
- Princeton University (Molecular Biology, with honors)
- Yale University School of Medicine — M.D., 1992
- Brigham and Women's Hospital General Surgery Internship (1993)
- Brigham and Women's Hospital General Surgery Residency (1994)
- Brigham and Women's Hospital Urology Residency (1998)
Peer Recognition
- Boston Super Doctors — Super Doctor
- Castle Connolly — Top Doctor
2017-2026 (10 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Massachusetts General Hospital
- Massachusetts General Hospital, Boston, MA
Languages
English
Experience
30+ years in practice